In four patients, both neovascular and cellular PSMA expression were observed; two leiomyosarcomas (one with high and one with low PSMA expression), one dedifferentiated liposarcoma (with low PSMA expression) and one MPNST (with high PSMA expression). This evidence concerns the gene FOLH1 and malignant peripheral nerve sheath tumor.